Literature DB >> 21212273

Insulin-like growth factor-1 receptor transactivation modulates the inflammatory and proliferative responses of neurotensin in human colonic epithelial cells.

Dezheng Zhao1, Kyriaki Bakirtzi, Yanai Zhan, Huiyan Zeng, Hon Wai Koon, Charalabos Pothoulakis.   

Abstract

Neurotensin (NT) is a gastrointestinal neuropeptide that modulates intestinal inflammation and healing by binding to its high-affinity receptor NTR1. The dual role of NT in inflammation and healing is demonstrated in models of colitis induced by Clostridium difficile toxin A and dextran sulfate sodium, respectively, and involves NF-κB-dependent IL-8 expression and EGF receptor-mediated MAPK activation in human colonocytes. However, the detailed signaling pathways involved in these responses remain to be elucidated. We report here that NT/NTR1 coupling in human colonic epithelial NCM460 cells activates tyrosine phosphorylation of the insulin-like growth factor-1 receptor (IGF-1R) in a time- and dose-dependent manner. NT also rapidly induces Src tyrosine phosphorylation, whereas pretreatment of cells with the Src inhibitor PP2 before NT exposure decreases NT-induced IGF-1R phosphorylation. In addition, inhibition of IGF-1R activation by either its specific antagonist AG1024 or siRNA against IGF-1 significantly reduces NT-induced IL-8 expression and NF-κB-dependent reporter gene expression. Pretreatment with AG1024 also inhibits Akt activation and apoptosis induced by NT. Silencing of Akt expression by siRNA also substantially attenuates NT-induced IL-8 promoter activity and NF-κB-dependent reporter gene expression. This is the first report to indicate that NT transactivates IGF-1R and that this response is linked to Akt phosphorylation and NF-κB activation, contributing to both pro-inflammatory and tissue repair signaling pathways in response to NT in colonic epithelial cells. We propose that IGF-1R activation represents a previously unrecognized key pathway involved in the mechanisms by which NT and NTR1 modulate colonic inflammation and inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212273      PMCID: PMC3057861          DOI: 10.1074/jbc.M110.192534

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

Review 1.  Rho GTPases as therapeutic targets for the treatment of inflammatory diseases.

Authors:  Dezheng Zhao; Charalabos Pothoulakis
Journal:  Expert Opin Ther Targets       Date:  2003-10       Impact factor: 6.902

2.  The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1973-10-10       Impact factor: 5.157

Review 3.  Fundamental mechanisms of growth failure in inflammatory bowel disease.

Authors:  Anne Ballinger
Journal:  Horm Res       Date:  2002

4.  Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-kappa B pathways.

Authors:  Dezheng Zhao; Sabina Kuhnt-Moore; Huiyan Zeng; Jack S Wu; Mary P Moyer; Charalabos Pothoulakis
Journal:  Am J Physiol Cell Physiol       Date:  2003-02-12       Impact factor: 4.249

5.  Metalloproteinase-dependent transforming growth factor-alpha release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells.

Authors:  Dezheng Zhao; Yanai Zhan; Hon Wai Koon; Huiyan Zeng; Sarah Keates; Mary P Moyer; Charalabos Pothoulakis
Journal:  J Biol Chem       Date:  2004-07-06       Impact factor: 5.157

6.  Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase.

Authors:  Peter Zahradka; Brenda Litchie; Ben Storie; Gail Helwer
Journal:  Endocrinology       Date:  2004-02-19       Impact factor: 4.736

7.  Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes.

Authors:  Hon-Wai Koon; Dezheng Zhao; Xi Na; Mary P Moyer; Charalabos Pothoulakis
Journal:  J Biol Chem       Date:  2004-08-19       Impact factor: 5.157

8.  Secretion of neurotensin and its effects on the jejunum in the dog.

Authors:  P G Reasbeck; G O Barbezat; A Shulkes; J Leader
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

9.  Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells.

Authors:  Sazzad Hassan; Paul R Dobner; Robert E Carraway
Journal:  Regul Pept       Date:  2004-08-15

10.  Characterization of radioimmunoassayable neurotensin in the rat. Its differential distribution in the central nervous system, small intestine, and stomach.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

View more
  27 in total

Review 1.  Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology.

Authors:  Ivy Ka Man Law; David Miguel Padua; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-08-03       Impact factor: 4.052

2.  MicroRNA-133α regulates neurotensin-associated colonic inflammation in colonic epithelial cells and experimental colitis.

Authors:  Ivy Ka Man Law; Charalabos Pothoulakis
Journal:  RNA Dis       Date:  2015

3.  Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors.

Authors:  Kyriaki Bakirtzi; Maria Hatziapostolou; Iordanes Karagiannides; Christos Polytarchou; Savina Jaeger; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Gastroenterology       Date:  2011-07-30       Impact factor: 22.682

Review 4.  Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

Authors:  A R M Ruhul Amin; Phillip A Karpowicz; Thomas E Carey; Jack Arbiser; Rita Nahta; Zhuo G Chen; Jin-Tang Dong; Omer Kucuk; Gazala N Khan; Gloria S Huang; Shijun Mi; Ho-Young Lee; Joerg Reichrath; Kanya Honoki; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; W Nicol Keith; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Hiromasa Fujii; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang; Alan Bilsland; Dong M Shin
Journal:  Semin Cancer Biol       Date:  2015-03-06       Impact factor: 15.707

Review 5.  The expansion of GPCR transactivation-dependent signalling to include serine/threonine kinase receptors represents a new cell signalling frontier.

Authors:  Danielle Kamato; Muhamad Ashraf Rostam; Rebekah Bernard; Terrence J Piva; Nitin Mantri; Daniel Guidone; Wenhua Zheng; Narin Osman; Peter J Little
Journal:  Cell Mol Life Sci       Date:  2014-11-12       Impact factor: 9.261

6.  Neurotensin-induced proinflammatory signaling in human colonocytes is regulated by β-arrestins and endothelin-converting enzyme-1-dependent endocytosis and resensitization of neurotensin receptor 1.

Authors:  Ivy Ka Man Law; Jane E Murphy; Kyriaki Bakirtzi; Nigel W Bunnett; Charalabos Pothoulakis
Journal:  J Biol Chem       Date:  2012-03-13       Impact factor: 5.157

7.  miR-143 inhibits bladder cancer cell proliferation and enhances their sensitivity to gemcitabine by repressing IGF-1R signaling.

Authors:  Hengbing Wang; Qi Li; Xiaobing Niu; Gongcheng Wang; Sinian Zheng; Guangbo Fu; Zengjun Wang
Journal:  Oncol Lett       Date:  2016-11-16       Impact factor: 2.967

Review 8.  Acquired resistance to drugs targeting receptor tyrosine kinases.

Authors:  Steven A Rosenzweig
Journal:  Biochem Pharmacol       Date:  2011-12-26       Impact factor: 5.858

Review 9.  Acquired Resistance to Drugs Targeting Tyrosine Kinases.

Authors:  Steven A Rosenzweig
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

10.  Anti-melanin-concentrating hormone treatment attenuates chronic experimental colitis and fibrosis.

Authors:  Dimitrios C Ziogas; Beatriz Gras-Miralles; Sarah Mustafa; Brenda M Geiger; Robert M Najarian; Jutta M Nagel; Sarah N Flier; Yury Popov; Yu-Hua Tseng; Efi Kokkotou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-03-28       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.